ATE340262T1 - Gruppen von borrelia burgdorferi, die lyme krankheit verursachen - Google Patents

Gruppen von borrelia burgdorferi, die lyme krankheit verursachen

Info

Publication number
ATE340262T1
ATE340262T1 AT00942966T AT00942966T ATE340262T1 AT E340262 T1 ATE340262 T1 AT E340262T1 AT 00942966 T AT00942966 T AT 00942966T AT 00942966 T AT00942966 T AT 00942966T AT E340262 T1 ATE340262 T1 AT E340262T1
Authority
AT
Austria
Prior art keywords
lyme disease
ospc
groups
borrelia burgdorferi
borrelia
Prior art date
Application number
AT00942966T
Other languages
English (en)
Inventor
Raymond J Dattwyler
Gerald Seinost
Daniel Dykhuizen
Benjamin J Luft
Maria Gomes-Solecki
Original Assignee
Univ New York State Res Found
Brook Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Brook Biotechnologies Inc filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE340262T1 publication Critical patent/ATE340262T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
AT00942966T 1999-06-18 2000-06-19 Gruppen von borrelia burgdorferi, die lyme krankheit verursachen ATE340262T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14004299P 1999-06-18 1999-06-18

Publications (1)

Publication Number Publication Date
ATE340262T1 true ATE340262T1 (de) 2006-10-15

Family

ID=22489483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942966T ATE340262T1 (de) 1999-06-18 2000-06-19 Gruppen von borrelia burgdorferi, die lyme krankheit verursachen

Country Status (9)

Country Link
US (2) US7060281B1 (de)
EP (2) EP1194559B1 (de)
AT (1) ATE340262T1 (de)
AU (1) AU5751000A (de)
DE (1) DE60030859T2 (de)
DK (1) DK1194559T3 (de)
ES (1) ES2272296T3 (de)
PT (1) PT1194559E (de)
WO (1) WO2000078966A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060281B1 (en) * 1999-06-18 2006-06-13 Research Foundation Of The State University Of New York Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
EP1939294A1 (de) 2000-08-18 2008-07-02 Research Foundation Of State University Of New York Rekombinante Konstrukte von Borrelia Burgdorferi
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
WO2006014292A2 (en) * 2004-07-02 2006-02-09 Dattwyler Raymond J Oral vaccine for borrelia
JP5390189B2 (ja) 2005-11-29 2014-01-15 ヴァージニア コモンウェルス ユニバーシティ 多価キメラｏｓｐｃワクシノーゲンおよび診断用抗原
KR102557888B1 (ko) 2006-01-19 2023-07-19 마리 케이 인코포레이티드 카카두 플럼 추출물 또는 아카이 베리 추출물을 포함하는 조성물
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167537A2 (de) 2007-07-03 2010-03-31 Dako Denmark A/S Zusammengestellte verfahren für die analyse und sortierung von proben
EP2197908A2 (de) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2009131665A1 (en) 2008-04-22 2009-10-29 Research Foundation Of State University Of New York Borrelia burgdorferi cell envelope protein array
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
FR2949472B1 (fr) 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
US20160097768A1 (en) 2010-10-20 2016-04-07 Virginia Commonwealth University Polyvalent chimeric ospc vaccinogen and diagnostic antigen
AU2011317105B2 (en) * 2010-10-20 2018-04-05 Virginia Commonwealth University Polyvalent chimeric OspC vaccinogen and diagnostic antigen
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
EP2809348B1 (de) * 2012-02-01 2018-11-07 Biopeptides Corporation Diagnostische peptide für lyme-borreliose
US9562079B2 (en) 2012-04-18 2017-02-07 Zoetis Services Llc Vaccines and methods to treat lyme disease in dogs
RU2514230C1 (ru) * 2012-12-14 2014-04-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт биохимии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ биохимии" СО РАМН) Рекомбинантные химерные полипептиды, несущие эпитопы различных иммунодоминантных белков спирохет комплекса borrelia burgdorferi sensu lato, и способ серодиагностики иксодового клещевого боррелиоза
WO2016057562A1 (en) 2014-10-07 2016-04-14 The Research Foundation For The State University Of New York Recombinant borrelia proteins and methods of use thereof
US11209431B2 (en) 2015-10-06 2021-12-28 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
AU689466B2 (en) 1993-02-26 1998-04-02 Cambridge Biotech Corporation Methods of inducing immunity to lyme disease and a colorimetric assay for borreliacidal activity of antisera
DK0701612T3 (da) 1993-04-29 1998-09-21 Immuno Ag Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti
EP0726955B1 (de) * 1993-11-01 2004-04-07 Brookhaven Science Associates Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
AU2207195A (en) * 1994-04-05 1995-10-23 Board Of Regents, The University Of Texas System Modified receptors that continuously signal
AR003941A1 (es) * 1995-04-19 1998-09-30 Polymun Scient Immunbilogische Forschung Gmbh Anticuerpos monoclonales humanos neutralizadores de hiv-1
US5804427A (en) * 1995-05-19 1998-09-08 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5683903A (en) * 1995-05-30 1997-11-04 Smithkline Beecham Corporation Attachment enhanced 293 cells
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US5849891A (en) * 1995-07-28 1998-12-15 National Science Council Satellite RNA from bamboo mosaic virus as a vector for foreign gene expression in plants
GB9517585D0 (en) * 1995-08-29 1995-11-01 Cookson William O C Atopy diagnosis and therapy
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
GB9526218D0 (en) * 1995-12-21 1996-02-21 Gene Shears Pty Ltd DNA Sequences
WO1997039105A1 (en) * 1996-04-18 1997-10-23 The Johns Hopkins University Mad-related genes in the human
DE69718903T2 (de) 1996-05-02 2003-12-04 Dakocytomation Denmark As Glos Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
US6110703A (en) * 1996-07-05 2000-08-29 Novo Nordisk A/S Method for the production of polypeptides
US5824318A (en) * 1996-07-24 1998-10-20 American Cyanamid Company Avirulent herpetic viruses useful as tumoricidal agents and vaccines
CA2265500C (en) * 1996-09-11 2010-04-13 Sumitomo Pharmaceuticals Co., Ltd. Novel semaphorin gene: semaphorin y
US6131578A (en) * 1996-10-02 2000-10-17 King; George L. Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
WO1998040404A2 (en) 1997-03-11 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6420108B2 (en) * 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6150081A (en) * 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
AU758663B2 (en) * 1998-02-17 2003-03-27 Bristol-Myers Squibb Company Members of the D52 gene family
PT1068302E (pt) * 1998-04-01 2005-10-31 Danisco Exoamilases nao maltogenicas e sua utilizacao no retardamento da retrogrdacao do amido
US6245525B1 (en) * 1998-07-27 2001-06-12 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
WO1999055840A1 (en) * 1998-04-27 1999-11-04 The Regents Of The University Of California A transcription factor and method for regulation of seed development, quality and stress-tolerance
DE69938183T2 (de) 1998-07-31 2009-02-19 Gundersen Lutheran Medical Foundation, Inc., La Crosse Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
US6627193B1 (en) * 1999-01-13 2003-09-30 University Of Georgia Research Foundation, Inc. Methods and compositions for control of blood coagulation
US6468773B1 (en) * 1999-05-19 2002-10-22 Genencor International, Inc. Mutant 1,3-propandiol dehydrogenase
US7060281B1 (en) * 1999-06-18 2006-06-13 Research Foundation Of The State University Of New York Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
WO2001013105A1 (en) * 1999-07-30 2001-02-22 Agy Therapeutics, Inc. Techniques for facilitating identification of candidate genes
US6472154B1 (en) * 1999-12-31 2002-10-29 Board Of Regents, The University Of Texas System Polymorphic repeats in human genes
US6337208B1 (en) * 2000-01-03 2002-01-08 Stefan Graupner Cloning vector

Also Published As

Publication number Publication date
DK1194559T3 (da) 2007-02-05
DE60030859T2 (de) 2007-06-14
DE60030859D1 (de) 2006-11-02
PT1194559E (pt) 2007-01-31
ES2272296T3 (es) 2007-05-01
US7582304B2 (en) 2009-09-01
EP1194559B1 (de) 2006-09-20
US7060281B1 (en) 2006-06-13
WO2000078966A1 (en) 2000-12-28
AU5751000A (en) 2001-01-09
EP1683867B1 (de) 2014-04-09
EP1683867A1 (de) 2006-07-26
US20090060932A2 (en) 2009-03-05
EP1194559A1 (de) 2002-04-10
US20060182756A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
ATE340262T1 (de) Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
DE60040012D1 (de) Rekombinantes gelatin in impstoffen
DE59911989D1 (de) Knochendistraktionsvorrichtung
MX9206720A (es) Grapa quirurgica polimerica.
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
DE69022115D1 (de) Hämostatische, chirurgische Clips.
DE69032679T2 (de) Threo (2R, 3S)-3-amino-2-hydroxypentansäure und threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentansäure
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
DZ1835A1 (fr) Nouvelles formulations.
DE50013608D1 (de) PIEZOELEKTRISCHER ANTRIEB, sowie System mit piezoelektrischem Antrieb und Schaltungsanordnung
DE59708975D1 (de) Presslinge auf Basis von pyrogen hergestelltem Siliciumdioxid
DE69416634T2 (de) Anorganische, abbindende Zusammensetzung
IT8920486A0 (it) Composizioni farmaceutiche.
ATE381575T1 (de) Veränderte borrelia burgdorferi ospa
DE60110683D1 (de) IgE-abhängiger histamin-freisetzender Faktor Rezeptor, bindende Peptide, dafür kodierende Nukleinsäuren und ihre Verwendungen
FI941851A0 (fi) Borrelia Burgdorferi -organismin (Bb) virulenssiin liittyvät proteiinit
ATE291080T1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
DE59208622D1 (de) Dentalwerkstoffe auf Basis von (Meth)-Acrylaten
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
IT1272612B (it) Dispositivo di cortocircuitazione, particolarmente per elettrolizzatori mono e bipolari e simili

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1194559

Country of ref document: EP